Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Impel Pharmaceuticals (IMPL)
OTHER OTC:IMPL
Holding IMPL?
Track your performance easily
IMPL Stock Chart & Stats
Day’s Range$0.23 - $0.44
52-Week Range― - ―
Previous Close$0.41
Volume858.52K
Average Volume (3M)N/A
Market Cap
$1.40M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next Earnings
Mar 22, 2024EPS Estimate
-$0.21Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering1
Impel Pharmaceuticals News
PremiumPre-Earnings
Is IMPL a Buy, Before Earnings?
Ownership Overview
0.00% Insiders
0.00% Mutual Funds
67.84% Other Institutional Investors
32.16% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
IMPL FAQ
What was Impel Pharmaceuticals’s price range in the past 12 months?
Currently, no data Available
What is Impel Pharmaceuticals’s market cap?
Currently, no data Available
When is Impel Pharmaceuticals’s upcoming earnings report date?
Impel Pharmaceuticals’s upcoming earnings report date is Mar 22, 2024 which is 249 days ago.
How were Impel Pharmaceuticals’s earnings last quarter?
Impel Pharmaceuticals released its earnings results on Nov 13, 2023. The company reported -$0.36 earnings per share for the quarter, the consensus estimate of -$0.36 by $0.
Is Impel Pharmaceuticals overvalued?
According to Wall Street analysts Impel Pharmaceuticals’s price is currently Overvalued.
Does Impel Pharmaceuticals pay dividends?
Impel Pharmaceuticals does not currently pay dividends.
What is Impel Pharmaceuticals’s EPS estimate?
Impel Pharmaceuticals’s EPS estimate is -$0.21.
How many shares outstanding does Impel Pharmaceuticals have?
Currently, no data Available
What happened to Impel Pharmaceuticals’s price movement after its last earnings report?
Impel Pharmaceuticals reported an EPS of -$0.36 in its last earnings report, expectations of -$0.36. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Impel Pharmaceuticals?
Among the largest hedge funds holding Impel Pharmaceuticals’s share is Gilder Gagnon Howe & Co LLC.. It holds Impel Pharmaceuticals’s shares valued at N/A.
---
Impel Pharmaceuticals Stock Smart Score
Company Description
Impel Pharmaceuticals
Impel NeuroPharma Inc is a late-stage pharmaceutical company focused on utilizing its proprietary technology to develop and commercialize transformative therapies for patients suffering from diseases with high unmet medical needs, with an initial focus on diseases of the central nervous system. Its pipeline of proprietary product candidates includes INP107 for the treatment of OFF episodes in Parkinson's Disease.
---
IMPL Earnings Call
Q1 2023
0:00 / 0:00
---
IMPL Stock 12 Month Forecast
Average Price Target
―Technical Analysis
---